When we hear about using AI in drug discovery, we tend to imagine the stage where it "thinks up new molecules."However, ...
Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to new research ...
Transforming drug development requires looking beyond discovery AI to precision patient stratification, avoiding the $2.67B ...
Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...
Stockhead on MSN
Health check: In drug development, the rich-poor divide widens
A dichotomy has emerged between the cash-rich drug developers and those struggling to survive. Let's call it life. ... Read ...
Moving a potential therapy from the laboratory to the pharmacy has always been a slow, incremental journey. “Drug development is a multi-stage process,” says Nichola McCann, associate principal ...
The globalization of biopharmaceutical innovation is likely to continue. The central challenge therefore is whether the US can use the heightened competition as a catalyst to strengthen its domestic ...
The obstructive sleep apnea competitive landscape report delivers important insights into approved as well as ongoing research on 22+ pipeline obstructive sleep apnea drugs, clinical strategies, ...
WASHINGTON — Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results